How is postnatal depression different from the baby blues?

Baby blues affect 50–80% of new mothers and appear on days 3–10, driven by the abrupt postpartum hormonal shift. Symptoms include tearfulness, emotional lability, irritability, and anxiety, but resolve spontaneously within two weeks without treatment beyond reassurance and monitoring. Postnatal depression, by contrast, persists beyond two weeks, causes functional impairment, and meets criteria for a depressive episode — persistent low mood, anhedonia, sleep disruption beyond infant demands, worthlessness, concentration difficulties, and in severe cases suicidality. The key clinical question is trajectory: symptoms still worsening or not resolving at two weeks warrant EPDS reassessment and active management.

Which antidepressant is safest while breastfeeding?

Sertraline 50–100 mg per day is the first-line SSRI in breastfeeding PND. It has the lowest measured infant plasma levels of the SSRIs, the largest safety dataset, and no consistent signal of adverse neurodevelopmental outcomes. Paroxetine is also acceptable in breastfeeding but avoid initiating it if the woman plans another pregnancy soon, as it carries a small first-trimester cardiac signal. Escitalopram is a reasonable alternative. Fluoxetine has a long half-life with measurable infant accumulation and is generally reserved for women already stabilised on it. For case-specific advice, MotherSafe NSW (1800 647 848) provides real-time breastfeeding pharmacology support.

What is postpartum psychosis and when should I call for emergency help?

Postpartum psychosis is a psychiatric emergency affecting one to two per 1,000 births, typically within the first two weeks. It presents with rapidly shifting mood, confusion, disorganised thought, delusions, and hallucinations. It is not the same as PND. Call emergency services or attend the nearest emergency department immediately. In most capital cities, mother-baby units (MBUs) are the preferred admission setting to preserve the mother–infant relationship. Known bipolar disorder carries a 50–70% postpartum relapse risk without prophylaxis, dropping to roughly 10% with lithium recommenced after delivery under specialist oversight.

What is the MDQ screen and why does it matter before starting an antidepressant?

The Mood Disorder Questionnaire (MDQ) is a brief self-report tool screening for bipolar spectrum disorder. Up to 20–40% of patients presenting with apparent PND may have undiagnosed bipolar disorder, where an SSRI started without a mood stabiliser can precipitate mania, mixed states, or rapid cycling. The MDQ, combined with a history of hypomanic episodes and a family history inquiry, should be completed before initiating any antidepressant in the postpartum period. A positive MDQ triggers referral to perinatal psychiatry or a GP with psychiatry experience before prescribing.

Where can an Australian family get help for postnatal depression?

PANDA (Perinatal Anxiety and Depression Australia) operates a national helpline on 1300 726 306 and provides peer support, information, and referral. beyondblue's Healthy Families site offers evidence-based information. MumMoodBooster is an Australian-developed free digital CBT program for PND. This Way Up provides Medicare-co-funded online CBT via a Mental Health Care Plan. General practitioners can initiate a Mental Health Care Plan (MHCP) for Better Access psychology sessions — up to 10 individual sessions per calendar year. Fathers and co-parents with PND are also eligible for their own MHCP.

Postnatal depression

Postnatal depression: AU general practice assessment and management

By Dr HB Lo, FACRRM Reviewed 8 June 2026 8 min read

Postnatal depression (PND) affects 10–16% of Australian mothers and 5–10% of fathers in the first year after birth — distinct from baby blues (days 3–10) and from postpartum psychosis.

Screen with the Edinburgh Postnatal Depression Scale (EPDS). A score of 13 or above warrants management; any self-harm response on question 10 requires immediate face-to-face response. Complete the MDQ before starting any SSRI to exclude bipolar disorder.

Mild to moderate PND responds to CBT or interpersonal therapy; moderate to severe warrants therapy plus sertraline — the preferred SSRI in breastfeeding.

Postnatal depression is the most common serious mental health complication of childbirth, yet it is frequently missed, minimised, or mistaken for normal postpartum adjustment. Approximately 10–16% of Australian mothers develop a depressive episode in the first 12 months after birth — that is roughly one in seven. Around 5–10% of fathers and co-parents are also affected, though they are screened far less systematically.

The consequences of untreated PND extend beyond the mother: maternal suicide is the leading direct cause of late maternal mortality in Australia, ahead of haemorrhage and sepsis. Infant attachment, cognitive development, and family functioning are all adversely affected. The good news is that effective treatments exist, and general practice is ideally placed to screen, identify, and coordinate care.

COPE’s 2023 Australian Perinatal Mental Health Guideline is the primary clinical framework for this work. The RANZCP Mood Disorders CPG, eTG Psychotropic, and NICE NG192 are supporting references.

A. Core clinical — the AU general-practice framework

The spectrum to distinguish

Baby blues — affects 50–80% of new mothers; transient mood lability, tearfulness, and irritability in the first 10 days; resolves by two weeks without treatment.

Postnatal depression (PND) — depressive episode meeting criteria, arising within 12 months of birth. DSM-5 uses a narrower peripartum specifier (within four weeks of delivery), but AU clinical practice and COPE 2023 extend the window to 12 months.

Postpartum psychosis — psychiatric emergency; onset typically within two weeks of delivery; mood-incongruent delusions, hallucinations, and confusion; affects one to two per 1,000 births.

Postpartum OCD — intrusive ego-dystonic thoughts (horrifying to the mother, not acted upon, often prompting avoidance of the infant); frequently misidentified as psychosis; requires specific cognitive-behavioural therapy.

Paternal PND — approximately 5–10% of fathers; under-recognised; when maternal PND is present, screen the partner.

Screening protocol

Universal screening with the Edinburgh Postnatal Depression Scale (EPDS) is the AU standard, administered at antenatal booking, 28 weeks gestation, and six weeks postpartum:

EPDS score 10–12: possible depression; repeat in two weeks
EPDS score ≥13: probable depression; initiate management
EPDS question 10 (self-harm): any positive response requires immediate face-to-face clinical response — do not allow the consultation to close without addressing it

Supplement with the K10 for general distress, and the Mood Disorder Questionnaire (MDQ) before any SSRI initiation — bipolar misclassification is a patient-safety issue.

Risk assessment domains

Key risk factors: prior depressive or anxiety episode, previous PND, personal or family history of bipolar disorder, birth trauma or emergency caesarean, NICU admission, infant difficulties (colic, sleep), postpartum thyroiditis, iron-deficiency anaemia, domestic and family violence (which peaks in the postpartum period), financial stress, social isolation, and ATSI or CALD background with reduced service access.

History in the consultation

Ask systematically: mood, anhedonia, sleep, energy, appetite, concentration, guilt/worthlessness, and suicidal ideation. Directly assess infant safety — can the mother feed and care for herself and the baby? Does she have thoughts of harming the infant? If yes, carefully distinguish ego-dystonic OCD intrusive thoughts (frightening to her, never acted on) from mood-congruent psychotic ideation, which is a safety emergency.

Ask sensitively about domestic and family violence using the HARK screen or a simple direct question in a private setting. 1800RESPECT (1800 737 732) is the national DFV crisis resource.

Investigations

Order TSH (postpartum thyroiditis affects 5–10%), FBC and ferritin (postpartum anaemia is extremely common and amplifies depressive symptoms), vitamin D (restricted PBS eligibility — postnatal women qualify), B12 and folate, and HbA1c if gestational diabetes was present.

B. Treatment principles and pharmacotherapy

Mild to moderate PND

Psychoeducation is the foundation — name the illness, normalise it, reduce stigma, and involve the partner with consent. The framing that PND is a physiological event with effective treatment, not a failure of motherhood, matters greatly.

CBT or interpersonal therapy (IPT) first-line — COPE 2023 endorses both; IPT has particularly strong perinatal evidence. Access via MHCP (items 2715/2717) with 10 individual Better Access psychology sessions per calendar year. Ten sessions is often not enough for severe or recurrent PND — escalate to the public perinatal service if the need exceeds Better Access.

Digital CBT via MumMoodBooster (AU-developed, free) and This Way Up Perinatal Wellbeing are Medicare co-funded under MHCP and reduce access barriers for rural and regional women.

Lifestyle — protect maternal sleep where infant care allows (partner or family rotating night feeds); aerobic exercise; adequate nutrition; sunlight exposure; connection with mothers’ groups and peer support via PANDA 1300 726 306.

Moderate to severe PND

Combine CBT/IPT with pharmacotherapy. Sertraline 50 mg (titrate to 100 mg) is the preferred first-line SSRI in breastfeeding — it has the lowest measured infant plasma transfer and the largest safety dataset of all SSRIs in lactation. eTG Psychotropic and COPE 2023 both recommend sertraline as the preferred agent.

Always screen with MDQ before initiating — if positive, refer to perinatal psychiatry before prescribing, as antidepressant monotherapy in undiagnosed bipolar can precipitate mania or rapid cycling.

Paroxetine is acceptable in breastfeeding but avoid newly initiating if there is another pregnancy planned (small first-trimester cardiac signal). Escitalopram is a reasonable alternative. Fluoxetine should be reserved for women already stabilised on it (long half-life, measurable infant accumulation). Venlafaxine is associated with significant infant withdrawal risk and is reserved for SSRI failures.

Severe PND and postpartum psychosis

Mother-baby unit (MBU) admission is preferred when available — it preserves the mother–infant relationship during intensive treatment. MBUs exist in Victoria (Royal Women’s, Monash), NSW (St John of God Burwood, Westmead), and Queensland (Belmont Private); rural access is frequently a barrier.

Antipsychotics (olanzapine, quetiapine — compatible with breastfeeding under monitoring) and mood stabilisers as required. Sodium valproate is contraindicated in women of childbearing potential due to high teratogenicity. Lithium is highly effective for postpartum bipolar prophylaxis but requires careful consideration of breastfeeding — specialist co-management is essential.

ECT is effective and safe in severe melancholic PND and postpartum psychosis, and is not contraindicated in breastfeeding.

C. Safety planning and medico-legal obligations

Every postnatal woman with PND should have a documented safety plan covering: warning signs, support contacts, crisis lines (PANDA 1300 726 306, Beyond Blue 1300 22 4636, Lifeline 13 11 14), means restriction (safe medication storage), and a named emergency contact. Provide the plan in writing and document in the clinical notes.

When infant safety is actively threatened — not ego-dystonic OCD intrusive thoughts but genuine risk — state mandatory child protection reporting obligations apply. Preserving the therapeutic alliance where possible is important; involve a social worker or perinatal service in the response.

Medico-legal exposure concentrates around: failure to screen with EPDS at recommended intervals; starting SSRI without a bipolar screen; not distinguishing ego-dystonic OCD from psychosis; inadequate documentation of safety plan and crisis-line provision; and premature discharge from perinatal follow-up at the six-week postnatal cliff.

D. Australian operations

MBS billing. Standard consults 23, 36, and 44. The six-week postnatal review (item 16407) includes universal EPDS rescreening and maternal physical review. MHCP preparation (item 2715 or 2717) with annual review (item 2712). GP Chronic Condition Management Plan (items 965/967) if comorbid chronic disease. Pregnancy support counselling (items 4001/4003/4005) — three sessions per pregnancy for GPs, eligible midwives, social workers, and psychologists. Multidisciplinary case conferencing (items 735–747) for severe or complex cases requiring perinatal psychiatry coordination. ATSI Health Assessment (item 715) integrates perinatal mental health screening in a culturally safe framework.

PBS. Sertraline, paroxetine, escitalopram, and fluoxetine are all general schedule — no authority required. Antipsychotics olanzapine and quetiapine are general schedule for acute use. Lithium carbonate is general schedule but requires specialist co-management in the perinatal context. Sodium valproate must not be used in women of childbearing potential. Brexanolone and zuranolone (neurosteroid agents FDA-approved for PND in the US) are not TGA-registered or PBS-listed in Australia as of June 2026. For case-specific breastfeeding pharmacology questions, MotherSafe NSW (1800 647 848) provides expert advice.

Telehealth. Standard existing-relationship rules apply. Useful for remote follow-up after initial in-person MHCP assessment; severely affected women unable to leave home benefit significantly.

E. Special populations

Aboriginal and Torres Strait Islander mothers. PND rates are higher and service access more limited. The Kimberley Mum’s Mood Scale is a validated screening tool for ATSI women. Aboriginal Medical Services, Aboriginal and Islander Health Workers, and ATSI-specific perinatal support are the culturally safe pathways. Avoid using family members as interpreters for sensitive mental health questions.

CALD and refugee women. Under-detection is common due to cultural expression of distress, language barriers, and stigma. Professional interpreters, bicultural mental health workers, and STARTTS (NSW Service for the Treatment and Rehabilitation of Torture and Trauma Survivors) for refugee populations.

Fathers and co-parents. Paternal PND rises when maternal PND is present. Offer the father an independent GP review and EPDS. PANDA provides father-specific information and peer support.

Women with prior bipolar disorder. Lithium prophylaxis reduces postpartum relapse from 50–70% to approximately 10% in known bipolar disorder — recommend restarting immediately after delivery under specialist co-management. Breastfeeding considerations must be individualised; specialist guidance from RANZCP is essential.

DVA-eligible women. Veterans and current serving members are eligible for perinatal mental health treatment under DVA mental health non-liability care, regardless of service connection.

When to escalate

Escalate or refer when:

Postpartum psychosis or suicidality with means or plan — emergency department, perinatal psychiatry, and MBU same-day
Infanticidal mood-congruent ideation — child protection notification plus emergency psychiatric assessment
Severe PND, bipolar postpartum, severe OCD or PTSD — perinatal psychiatry, MBU outpatient
PND not responding to first-line after four to six weeks — perinatal psychiatry or GP psychiatry opinion
Active domestic and family violence — 1800RESPECT, local DV service, safety planning
Preconception planning after prior PND — perinatal psychiatry consult to plan medication strategy

What this article is and is not

This is general health information drawn from the COPE 2023 Australian Perinatal Mental Health Guideline, RANZCP Mood Disorders CPG, eTG Psychotropic, RACGP guidelines, NICE NG192, and PANDA clinical resources. It is not personal medical advice and does not create a doctor–patient relationship. Decisions about screening, psychological therapy, medication choice, and referral are made with your own GP, midwife, or treating clinicians.

For support: PANDA 1300 726 306, Beyond Blue 1300 22 4636, Lifeline 13 11 14, 13YARN 13 92 76, 1800RESPECT 1800 737 732. For AU consumer-friendly information: HealthDirect — Postnatal depression, beyondblue Healthy Families, MumMoodBooster.

Sources cited

Frequently asked questions

How is postnatal depression different from the baby blues?

Baby blues affect 50–80% of new mothers and appear on days 3–10, driven by the abrupt postpartum hormonal shift. Symptoms include tearfulness, emotional lability, irritability, and anxiety, but resolve spontaneously within two weeks without treatment beyond reassurance and monitoring. Postnatal depression, by contrast, persists beyond two weeks, causes functional impairment, and meets criteria for a depressive episode — persistent low mood, anhedonia, sleep disruption beyond infant demands, worthlessness, concentration difficulties, and in severe cases suicidality. The key clinical question is trajectory: symptoms still worsening or not resolving at two weeks warrant EPDS reassessment and active management.
Which antidepressant is safest while breastfeeding?

Sertraline 50–100 mg per day is the first-line SSRI in breastfeeding PND. It has the lowest measured infant plasma levels of the SSRIs, the largest safety dataset, and no consistent signal of adverse neurodevelopmental outcomes. Paroxetine is also acceptable in breastfeeding but avoid initiating it if the woman plans another pregnancy soon, as it carries a small first-trimester cardiac signal. Escitalopram is a reasonable alternative. Fluoxetine has a long half-life with measurable infant accumulation and is generally reserved for women already stabilised on it. For case-specific advice, MotherSafe NSW (1800 647 848) provides real-time breastfeeding pharmacology support.
What is postpartum psychosis and when should I call for emergency help?

Postpartum psychosis is a psychiatric emergency affecting one to two per 1,000 births, typically within the first two weeks. It presents with rapidly shifting mood, confusion, disorganised thought, delusions, and hallucinations. It is not the same as PND. Call emergency services or attend the nearest emergency department immediately. In most capital cities, mother-baby units (MBUs) are the preferred admission setting to preserve the mother–infant relationship. Known bipolar disorder carries a 50–70% postpartum relapse risk without prophylaxis, dropping to roughly 10% with lithium recommenced after delivery under specialist oversight.
What is the MDQ screen and why does it matter before starting an antidepressant?

The Mood Disorder Questionnaire (MDQ) is a brief self-report tool screening for bipolar spectrum disorder. Up to 20–40% of patients presenting with apparent PND may have undiagnosed bipolar disorder, where an SSRI started without a mood stabiliser can precipitate mania, mixed states, or rapid cycling. The MDQ, combined with a history of hypomanic episodes and a family history inquiry, should be completed before initiating any antidepressant in the postpartum period. A positive MDQ triggers referral to perinatal psychiatry or a GP with psychiatry experience before prescribing.
Where can an Australian family get help for postnatal depression?

PANDA (Perinatal Anxiety and Depression Australia) operates a national helpline on 1300 726 306 and provides peer support, information, and referral. beyondblue's Healthy Families site offers evidence-based information. MumMoodBooster is an Australian-developed free digital CBT program for PND. This Way Up provides Medicare-co-funded online CBT via a Mental Health Care Plan. General practitioners can initiate a Mental Health Care Plan (MHCP) for Better Access psychology sessions — up to 10 individual sessions per calendar year. Fathers and co-parents with PND are also eligible for their own MHCP.

Source quality

Sources grouped by evidence tier. AU primary tier first; international where AU is silent or lagging; named-author reconstruction where guidelines have not yet caught up. How tiers work.